Transhuman Capital Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 1

Professionals

  • Investments
  • 23

  • Portfolio
  • 15

  • Exits
  • 6

Exits

Transhuman Capital General Information

Company Description

Founded in 2014, Transhuman Capital is a venture capital firm based in Ann Arbor, Michigan. The firm seeks to invest in the therapeutics, biotechnology, medical devices, and healthcare technologies sectors.

Business Details

Year Founded
2014
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Corporate Office
  • Ann Arbor, MI
  • United States

Transhuman Capital Investments (23)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Cyana Therapeutics 01-Jul-2026 Early Stage VC Drug Discovery Pre-Clinical Trials
Ambros Therapeutics 16-Dec-2025 Biotechnology Clinical Trials - Phase 3
Response Pharmaceuticals 28-Jun-2024 Drug Discovery Clinical Trials - Phase 2
Retension Pharmaceutical 15-May-2024 Drug Discovery Generating Revenue/Not Profitable
Matter Bioworks 19-Apr-2024 Biotechnology Clinical Trials - Phase 1
Nava Therapeutics 24-Jan-2024 Drug Discovery Generating Revenue
Kriya Therapeutics 26-Jul-2023 Drug Discovery Clinical Trials - General
Bond Biosciences 25-Jan-2022 Drug Discovery Clinical Trials - General
EVOQ Therapeutics 25-Oct-2021 Later Stage VC Drug Discovery Product Development
Eight Sleep 30-Aug-2021 Later Stage VC Electronics (B2C) Generating Revenue
You’re viewing 10 of 23 investments. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Transhuman Capital Exits (6)

Company Name Exit Date Exit Type Exit Size
Retension Pharmaceutical 09-Oct-2026 IPO
Asalyxa Bio 05-Jul-2024
Roivant Sciences 30-Sep-2021
Sio Gene Therapies 11-Jun-2015 IPO
Marinus Pharmaceuticals 31-Jul-2014 IPO
You’re viewing 5 of 6 exits. Get the full list »

Transhuman Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Transhuman Capital FAQs

  • What is Transhuman Capital?

    Founded in 2014, Transhuman Capital is a venture capital firm based in Ann Arbor, Michigan.

  • When was Transhuman Capital founded?

    Transhuman Capital was founded in 2014.

  • Where is Transhuman Capital headquartered?

    Transhuman Capital is headquartered in Ann Arbor, MI.

  • How many investments has Transhuman Capital made?

    Transhuman Capital has made 23 investments.

  • What has Transhuman Capital invested in?

    Transhuman Capital has made numerous investments in companies like Cyana Therapeutics, Ambros Therapeutics, and Response Pharmaceuticals within the Drug Discovery and Biotechnology industries.

  • What has Transhuman Capital invested in recently?

    Transhuman Capital's latest investment was on 01-Jul-2026 in Cyana Therapeutics, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process